成都先导
Investments
1
Lead Investments
0
HitGen Inc. (also known as 成都先导药物开发有限公司 / 先导药物) is a drug discovery research company headquartered in Chengdu, China, with subsidiaries in Cambridge (UK) and Houston (USA). It is listed on the Shanghai Stock Exchange (SSE: 688222).
Highlights
Focus Areas
Biopharma
Biotechnology
Medical
Notable Investments